GP0457B Migraines study US

Global Patients is conducting a study on behalf of Eli Lilly and Company with adults who have been diagnosed with episodic migraine. This means you have fewer than 15 monthly headache days or monthly migraine headache days.

The aim of the research is to understand the preferences of adults with episodic migraine towards preventive migraine treatments.

The research is completely anonymous, and no questions will be asked that could identify the participant. All data collected during this research will be treated anonymously and confidentially and analysed in aggregate form.

This study consists of an online survey in the United States, which will last around 20 minutes and for which you will receive a payment of $25. Remuneration amounts are subject to change.

If you are interested to participate, please contact

Join this Study
Are you already a member of Global Patients?